Protara Therapeutics, Inc. — Director's Dealing 2014

Oct 21, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2014-10-21

Reporting Person: BOHLIN GAREN G (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.00	2024-10-21	Common Stock (13333)		Direct

Footnotes

F1: The shares underlying this option vest annually over three years in three equal installments.

F2: Reflects a 1-for-15.87 reverse stock split effected on October 6, 2014.